Baqar’s Premier League 2025 Ignites Mumbai with a High-Voltage Cardio Night
Over 180+ global participants unite for an electrifying celebration of fitness, resilience,…
Stern School of Business at NYU Abu Dhabi releases inaugural Financial Center Competitiveness Index
Results rank New York, London, and Singapore as the top three global…
Crafted for Effortless Play, XXIO Introduces the AllNew XXIO 14
HUNTINGTON BEACH, Calif., Dec. 8, 2025 – Leading the way in ultralightweight,…
Hideki Matsuyama Shines on Sunday, Takes Hero World Challenge in Playoff
HUNTINGTON BEACH, Calif., Dec. 7, 2025 – Delivering a sizzling Sunday finish,…
MICHELIN Guide Returns to Vegas with Launch of New Southwest Edition
LAS VEGAS - Announced today, in partnership with Arizona, Nevada, New Mexico,…
Kia PV5 Cargo Achieves Maximum FiveStar Rating in 2025 Euro NCAP Commercial Van Safety Assessment
Kia PV5 Cargo earns the top five-star rating in the 2025 Euro…
Kia Launches Inspiration Connects Us All Campaign Ahead of FIFA World Cup 2026
New campaign highlights Kia’s commitment to promoting unity and connection for people…
Menarini Group Presents Elacestrant (ORSERDU) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium
In addition, the expansive elacestrant clinical development program updates reinforce its potential as…
Manipal Hospitals Enhances Movement and Confidence Through Awareness on Movement Disorders
BENGALURU, India, Dec. 8, 2025 /PRNewswire/ -- Parkinson's disease often begins far…
UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder
Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a…
